当前位置:首页 - 行情中心 - 国新健康(000503) - 财务分析 - 现金流量表

国新健康

(000503)

  

流通市值:101.44亿  总市值:101.66亿
流通股本:9.79亿   总股本:9.81亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金107,428,065.7735,128,905.66371,525,633.5189,635,196.23
  收到的税费返还185,139.2456,101.38-114,613.37
  收到其他与经营活动有关的现金13,562,991.479,981,546.6334,513,953.3627,751,765.34
  经营活动现金流入小计121,176,196.4845,166,553.67406,039,586.86217,501,574.94
  购买商品、接受劳务支付的现金33,170,012.7819,218,899.97100,814,121.9581,880,479.62
  支付给职工以及为职工支付的现金161,525,263.4966,912,149.17287,927,634.43219,308,392.55
  支付的各项税费7,774,936.95,496,840.2719,466,372.414,056,979.69
  支付其他与经营活动有关的现金38,180,118.0619,171,008.1280,320,735.9344,768,945.11
  经营活动现金流出小计240,650,331.23110,798,897.53488,528,864.71360,014,796.97
  经营活动产生的现金流量净额-119,474,134.75-65,632,343.86-82,489,277.85-142,513,222.03
二、投资活动产生的现金流量:
  收回投资收到的现金140,000,000-153,400,000112,400,000
  取得投资收益收到的现金2,800,000-14,195,706.1329,985
  处置固定资产、无形资产和其他长期资产收回的现金净额43,269.82---
  投资活动现金流入的平衡项目0-00
  投资活动现金流入小计142,843,269.82-167,595,706.13112,429,985
  购建固定资产、无形资产和其他长期资产支付的现金18,509,751.348,643,787.6637,620,225.6840,094,834.3
  投资支付的现金239,000,0009,000,000450,000,000-
  支付其他与投资活动有关的现金--1,135,0001,135,000
  投资活动现金流出小计257,509,751.3417,643,787.66488,755,225.6841,229,834.3
  投资活动产生的现金流量净额-114,666,481.52-17,643,787.66-321,159,519.5571,200,150.7
三、筹资活动产生的现金流量:
  取得借款收到的现金124,805,780.1715,000,000389,000,000285,000,000
  筹资活动现金流入小计124,805,780.1715,000,000389,000,000285,000,000
  偿还债务支付的现金11,135,332.389,000,000439,000,000290,000,000
  分配股利、利润或偿付利息支付的现金2,150,742.33942,7506,892,677.795,545,742.8
  支付其他与筹资活动有关的现金19,748,495.024,447,878.6317,833,752.6215,469,128.98
  筹资活动现金流出小计33,034,569.7314,390,628.63463,726,430.41311,014,871.78
  筹资活动产生的现金流量净额91,771,210.44609,371.37-74,726,430.41-26,014,871.78
四、汇率变动对现金及现金等价物的影响-190,997.69-27,988.79331,840.32-84,930.58
五、现金及现金等价物净增加额-142,560,403.52-82,694,748.94-478,043,387.49-97,412,873.69
  加:期初现金及现金等价物余额437,381,077.4434,086,077.4915,424,464.89915,421,376.59
  期末现金及现金等价物余额294,820,673.88351,391,328.46437,381,077.4818,008,502.9
补充资料:
  净利润-99,090,685.4--11,466,549.76-
  资产减值准备3,473,622.81-25,147,977.71-
  固定资产和投资性房地产折旧1,536,099.7-2,804,554.31-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧1,536,099.7-2,804,554.31-
  无形资产摊销12,275,325.39-25,761,033.74-
  长期待摊费用摊销517,676.98-1,300,763.29-
  处置固定资产、无形资产和其他长期资产的损失5,713.81--33,591.2-
  固定资产报废损失262,890.16-2,763.59-
  公允价值变动损失---6,340,000-
  财务费用4,860,130.34-8,310,544-
  投资损失-9,609,001.83--143,019,379.11-
  递延所得税4,463.38--638,853.03-
  其中:递延所得税资产减少4,463.38--19,882,903.33-
    递延所得税负债增加0-19,244,050.3-
  存货的减少-2,194,973.03-1,299,558.65-
  经营性应收项目的减少-44,869,239.83--40,668,941.97-
  经营性应付项目的增加5,442,549.62-50,776,592.57-
  其他---2,954,085.75-
  现金的期末余额294,820,673.88-437,381,077.4-
  减:现金的期初余额437,381,077.4-915,424,464.89-
  现金及现金等价物的净增加额-142,560,403.52--478,043,387.49-
公告日期2025-08-282025-04-252025-04-252024-10-26
审计意见(境内)标准无保留意见
TOP↑